Skip to content

Klotho gene therapy

Gene & frontier therapiesgene therapyEarly stage

Availability Not yet tested in people

What it is

Klotho is a protein named after the Greek fate who spins the thread of life. Mice engineered to make less of it age quickly and die young; mice engineered to make more live longer. Klotho gene therapy would deliver the gene for the secreted form of the protein, packaged in an adeno-associated virus, so that the body produces more of it on its own.

Why people choose this treatment

Nobody does, because nobody can. The interest is anticipatory. Klotho is one of very few single genes with a clean, repeated lifespan signal in mammals, its levels fall with age in people, and low levels track with kidney disease and cognitive decline. That combination has made it the most cited target in frontier longevity conversation, well ahead of anything you could act on.

How it's delivered

It is not delivered. In animal studies the vector is given once, into muscle or the bloodstream or the brain, and the change is meant to be permanent. No clinic, no medical tourism destination, and no patient-paid study offers klotho gene therapy today. Any offer encountered should be treated as fraudulent.

Where the evidence stands

Preclinical and genuinely promising, with no human evidence at all. A 2023 study delivering secreted klotho by viral vector to aged mice reported roughly a 20 percent increase in median lifespan in males, alongside better bone, muscle, and brain measures. A separate 2023 study found klotho protein improved cognition in aged rhesus monkeys, which is still a protein rather than a gene therapy and still not a person. The only company advancing a klotho gene therapy holds an orphan designation for ALS and is at the manufacturing stage, with a first single-dose human study planned rather than started. Nothing about dose, durability, or long-term safety in humans is known.

Estimated cost

There is no price because there is no product: as of the August 2026 research pass, klotho gene therapy has not entered human trials, no clinic anywhere offers it, and no patient-paid study is enrolling. Any offer encountered, at any price, should be treated as fraudulent.

Who offers it

Nobody. Klotho gene therapy has not entered human trials anywhere in the world, and there is no legitimate or illegitimate route to receiving it. We list it because it is discussed constantly and because that discussion is what tourism offers eventually attach themselves to.

How we know

Recorded from the published literature and company announcements on our last research pass. There is no provider to contact and we are not compensated for this entry.

Go deeper

No klotho guide yet. The science of aging hub covers the hallmarks of aging and what it would actually take for a single-gene finding in mice to become a treatment for people.

Explore the science of aging

Longevity.io is for educational purposes only and is not medical advice. We list klotho gene therapy so the record is clear: it is a preclinical idea with real supporting biology and no human data, and anyone offering it for sale is not offering what they claim.

Your Longevity Blueprint

Build your starting plan.

A few short questions, about two minutes. The Blueprint recommends where to start and explains why.

Build my Blueprint